ENDOMETRIOID ENDOMETRIAL CANCER
Clinical trials for ENDOMETRIOID ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ENDOMETRIOID ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive endometrial cancer: drug combo targets obesity link
Disease control Recruiting nowThis early-stage trial is testing the safety of combining two drugs, atezolizumab and ONC201, for people with advanced or recurrent endometrial cancer. The study includes both obese and non-obese participants to see how body weight affects treatment. The goal is to find the best …
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
New combo therapy shows promise for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis study tests whether combining a PD-1 inhibitor (camrelizumab) with chemotherapy before surgery can shrink advanced endometrial cancer (stage III-IV). About 39 adults aged 18-75 with this cancer type will receive the combo, then have surgery to remove any remaining tumor. The…
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New drug combo shows promise for Tough-to-Treat endometrial cancer
Disease control Recruiting nowThis study tests a combination of two drugs, nab-sirolimus and letrozole, in people with advanced or recurrent endometrioid endometrial cancer. The goal is to see if the combination can shrink or control tumors. About 29 participants will receive the treatment, and researchers wi…
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Aadi Bioscience, Inc. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC